Detalhe da pesquisa
1.
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Cell
; 184(15): 3949-3961.e11, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161776
2.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med
; 384(3): 238-251, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332778
3.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347950
4.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med
; 385(23): e81, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587383
5.
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
J Infect Dis
; 225(10): 1765-1772, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507266
6.
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
J Infect Dis
; 227(1): 23-34, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895508
7.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
8.
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Clin Infect Dis
; 73(11): e4400-e4408, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897368
9.
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S612-S626, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860496
10.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis
; 122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788416
11.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
JAMA Netw Open
; 5(8): e2225411, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969402
12.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv
; 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159343
13.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv
; 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159344
14.
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study.
Lancet Infect Dis
; 18(8): 884-893, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29929783
15.
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets.
Antiviral Res
; 156: 64-71, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29885377